Literature DB >> 8869946

Acute effects of L-tryptophan on brain extracellular 5-HT and 5-HIAA levels in chronic experimental portal-systemic encephalopathy.

P B Bergqvist1, S Hjorth, G Apelqvist, F Bengtsson.   

Abstract

Portal-systemic encephalopathy (PSE) is associated with increased brain turnover of serotonin (5-hydroxytryptamine; 5-HT). Despite this metabolic increase, neuronal release of 5-HT is unaltered in neocortex of portacaval shunted (PCS) rats. In the present study, frontal neocortical extracellular 5-HT and 5-hydroxyindole-3-acetic acid (5-HIAA) levels were determined in PCS rats and sham-operated controls prior to, as well as, after acute challenge with L-tryptophan (L-TRP; a bolus dose of 280 mg/kg i.p. followed by 5 consecutive hourly doses of 50 mg/kg). Neither basal 5-HT nor 5-HIAA extracellular levels were significantly altered in PCS rats compared to controls. L-TRP administration resulted in unaltered extracellular 5-HT but elevated 5-HIAA levels in PCS and sham rats. These findings do not suggest that changes in brain neuronal 5-HT release play any major functional role in the pathogenesis of chronic PSE. The present data also emphasize the importance of distinguishing between brain 5-HT metabolism and brain 5-HT release.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8869946     DOI: 10.1007/bf02237963

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  25 in total

1.  Portacaval shunt in the rat.

Authors:  S H LEE; B FISHER
Journal:  Surgery       Date:  1961-10       Impact factor: 3.982

Review 2.  Antidepressants and serotonergic neurotransmission: an integrative review.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

3.  Evidence for the synthesis and storage of 5-hydroxytryptamine in two separate pools in the brain.

Authors:  P J Shields; D Eccleston
Journal:  J Neurochem       Date:  1973-03       Impact factor: 5.372

4.  Abnormalities of indoleamines in affective disorders.

Authors:  A Coppen; A J Prange; P C Whybrow; R Noguera
Journal:  Arch Gen Psychiatry       Date:  1972-05

5.  Brain extracellular quinolinic acid in chronic experimental hepatic encephalopathy as assessed by in vivo microdialysis: acute effects of L-tryptophan.

Authors:  P B Bergqvist; M P Heyes; G Apelqvist; R F Butterworth; F Bengtsson
Journal:  Neuropsychopharmacology       Date:  1996-10       Impact factor: 7.853

6.  Portacaval anastomosis: brain and plasma metabolite abnormalities and the effect of nutritional therapy.

Authors:  A M Mans; J F Biebuyck; D W Davis; R A Hawkins
Journal:  J Neurochem       Date:  1984-09       Impact factor: 5.372

Review 7.  Tryptophan availability, 5HT synthesis and 5HT function.

Authors:  S N Young; K L Teff
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1989       Impact factor: 5.067

8.  Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.

Authors:  D G Grahame-Smith
Journal:  J Neurochem       Date:  1971-06       Impact factor: 5.372

9.  Tryptophan increases extracellular serotonin in the lateral hypothalamus of food-deprived rats.

Authors:  D H Schwartz; L Hernandez; B G Hoebel
Journal:  Brain Res Bull       Date:  1990-12       Impact factor: 4.077

10.  Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics.

Authors:  J N Joyce; A Shane; N Lexow; A Winokur; M F Casanova; J E Kleinman
Journal:  Neuropsychopharmacology       Date:  1993-06       Impact factor: 7.853

View more
  3 in total

1.  Oral tryptophan challenge studies in cirrhotic patients: no evidence of neuropsychiatric changes.

Authors:  Andrew Douglass; Hanan Al Mardini; Christopher O Record
Journal:  Metab Brain Dis       Date:  2003-09       Impact factor: 3.584

2.  Differentiation between the effects of unprocessed portal blood and reduced liver function on brain indole amine metabolism in the portacaval shunted rat.

Authors:  B Alexander; M Aslam; A Nobin; I S Benjamin
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

3.  A quantitative evaluation of the permeability of the blood brain barrier of portacaval shunted rats.

Authors:  B Alexander; X Li; I S Benjamin; M B Segal; R Sherwood; J E Preston
Journal:  Metab Brain Dis       Date:  2000-06       Impact factor: 3.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.